The short answer
Discuss SAMe augmentation with your prescriber. Official guidance describes possible serotonergic interactions, while supervised SRI trials have also reported benefit without serotonin syndrome.
What this answer covers
Oral SAMe, distinct from injected treatment and dietary methionine.
- Supplement or preparation
- S-Adenosylmethionine
- Medication ingredient
- fluoxetine
The precaution is possible interaction
NCCIH warns that SAMe may interact with serotonin-increasing medicines and highlights bipolar disorder. This supports review rather than a claim that every combination causes toxicity.
Controlled augmentation evidence also exists
A six-week randomized SRI augmentation trial found better depression outcomes with SAMe and no significant difference in adverse-event discontinuation. The original report states no serotonin syndrome occurred.
The fluoxetine subgroup remains unclear
Fluoxetine was eligible in the trial, but exact coexposure counts and outcomes were not established from the accessible material. The group result cannot quantify your specific risk.
Plan changes rather than relying on a gap
Bring your exact SAMe product and mood history to the prescriber. Fluoxetine and its active metabolite persist, so a short dose gap is not a validated way to remove an interaction concern.
Evidence and practical considerations
Side effects & toxicity
Conditional supervision/avoidance of self-directed use; no verified fluoxetine-specific serotonin-syndrome rate or timing rule.
- Exact scope
- Oral SAMe, distinct from injected treatment and dietary methionine. with Exact oral fluoxetine hydrochloride capsules. RxNorm IN 4493/PIN 227224 hydrochloride capsules. Active norfluoxetine and prolonged elimination matter. Not the combined olanzapine product.
- Medication form and route
- oral
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- Mixed-antidepressant trial does not establish fluoxetine coexposure counts or subgroup safety; long-term effects remain uncertain.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral fluoxetine.
Exact label names tryptophan and St John’s wort in serotonin warnings, warns about bleeding and mania, and describes long elimination of fluoxetine and norfluoxetine.
How this applies: RxNorm IN 4493/PIN 227224 hydrochloride capsules. Active norfluoxetine and prolonged elimination matter. Not the combined olanzapine product.
No universal supplement interval, event rate or preparation equivalence established. Original label distinguishes warnings from measured pair-specific results.
Source 2: official supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering SAMe.
Possible interaction with serotonin-increasing medicines and supplements; bipolar disorder and long-term safety deserve review.
How this applies: Supports supervised augmentation decisions.
Possible risk, not a fluoxetine-specific event frequency.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Seventy-three depressed patients who had not responded to serotonin reuptake inhibitors.
Response and remission favored SAMe without significant difference in adverse-event discontinuation; original publisher web text reported no serotonin syndrome.
How this applies: Only the named drug, preparation, route and measured endpoints apply.
Fluoxetine was an eligible antidepressant, but exact coexposure counts and drug-specific outcomes were not established. Publisher raw download 403; inspected original web excerpts retained in search-08.json.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. | |
| Research summary published |
Article revision: c9f0f05991d65712
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.